The Src family kinase inhibitor, Saracatinib, induced PTEN recruitment around parasites in neural tissue and impaired recruitment of activated Akt, causing a striking reduction in parasite load and histopathology in mice with ocular and cerebral toxoplasmosis. Here, PTEN is linked to cerebral toxoplasmosis.